All charts and data below are with dividends reinvested. (Inflation adjustment is OFF !)
IBB total return snapshot: IBB returned +36.49% over the past year and +21.14% YTD, with dividends reinvested. Since Feb. 9, 2001, IBB is up +533.49% in nominal total return, or +7.46%/yr, and is currently −5.85% below its total-return high on Aug. 19, 2026.
Data ending Mon Oct. 12, 2026
| Fri 2001-02-09💬 to Mon 2026-10-12 |
Overall
Return |
Exponential
Trendline |
||||
|---|---|---|---|---|---|---|
| IBB × |
+533.49%
+7.46%/yr |
+10.53%/yr
R2=0.887 |
||||
| iShares Biotechnology ETF NASDAQ Exchange-Traded Fund | ||||||
| Fri 2001-02-09💬 to Mon 2026-10-12 |
Start
Value |
End
Value |
|---|---|---|
| IBB × |
$10,000.00
2001-02-09 |
$63,349.40
2026-10-12 |
| YTD | YoY | |
|---|---|---|
| IBB × | +21.14% | +36.49% |
|
Current
Drawdown |
Worst
Drawdown |
|
|---|---|---|
| IBB × |
−5.85%
on 2026-10-12 from 2026-08-19 peak |
−62.85%
on 2002-07-10 from 2001-06-05 peak |
| Period ending Mon 2026-10-12 | 1 yr | 2 yr | 3 yr | 5 yr | 10 yr |
|---|---|---|---|---|---|
| IBB × | +36.49% |
+40.85% +18.68%/yr |
+69.83% +19.31%/yr |
+33.72% +5.98%/yr |
+132.70% +8.81%/yr |
| Year | IBB |
|---|---|
| 2026 (YTD) | +21.14% |
| 2025 | +27.98% |
| 2024 | −2.41% |
| 2023 | +3.76% |
| 2022 | −13.69% |
| 2021 | +0.95% |
| 2020 | +26.01% |
| 2019 | +25.42% |
| 2018 | −9.53% |
| 2017 | +21.08% |
| 2016 | −21.42% |
| 2015 | +11.56% |
| 2014 | +33.83% |
| 2013 | +65.54% |
| 2012 | +32.13% |
| 2011 | +11.72% |
| 2010 | +14.84% |
| 2009 | +15.17% |
| 2008 | −12.28% |
| 2007 | +4.52% |
| 2006 | +0.67% |
| 2005 | +2.44% |
| 2004 | +4.80% |
| 2003 | +45.79% |
| 2002 | −45.80% |
| 2001 | −9.90% |
